Literature DB >> 33450882

Expanding the Clinical and Mutational Spectrum of the PLP1-Related Hypomyelination of Early Myelinated Structures (HEMS).

Francesco Nicita1,2, Chiara Aiello1,2, Gessica Vasco3, Massimiliano Valeriani4, Fabrizia Stregapede1,2,5, Andrea Sancesario3,6, Michela Armando3, Enrico Bertini1,2.   

Abstract

The PLP1 gene, located on chromosome Xq22, encodes the proteolipid protein 1 and its isoform DM20. Mutations in PLP1 cause a spectrum of white matter disorders of variable severity. Here we report on four additional HEMS patients from three families harboring three novel PLP1 mutations in exon 3B detected by targeted next-generation sequencing. Patients experienced psychomotor delay or nystagmus in the first year of age and then developed ataxic-spastic or ataxic syndrome, compatible with a phenotype of intermediate severity in the spectrum of PLP1-related disorders. Regression occurred at the beginning of the third decade of the eldest patient. Extrapyramidal involvement was rarely observed. Brain MRI confirmed the involvement of structures that physiologically myelinate early, although the pattern of abnormalities may differ depending on the age at which the study is performed. These new cases contribute to expanding the phenotypic and genotypic spectrum of HEMS. Additional studies, especially enriched by systematic functional evaluations and long-term follow-up, are welcome to better delineate the natural history of this rare hypomyelinating leukodystrophy.

Entities:  

Keywords:  DM20; HEMS; PLP1; Pelizaeus-Merzbacher disease; exon 3B; hypomyelinating; intron 3; leukodystrophy; proteolipid protein 1

Year:  2021        PMID: 33450882      PMCID: PMC7828325          DOI: 10.3390/brainsci11010093

Source DB:  PubMed          Journal:  Brain Sci        ISSN: 2076-3425


  15 in total

1.  Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease.

Authors:  F Cailloux; F Gauthier-Barichard; C Mimault; V Isabelle; V Courtois; G Giraud; B Dastugue; O Boespflug-Tanguy
Journal:  Eur J Hum Genet       Date:  2000-11       Impact factor: 4.246

2.  A splicing mutation of proteolipid protein 1 in Pelizaeus-Merzbacher disease.

Authors:  Taku Omata; Jun-Ichi Nagai; Hiroko Shimbo; Shiro Koizume; Yohei Miyagi; Kenji Kurosawa; Sumimasa Yamashita; Hitoshi Osaka; Ken Inoue
Journal:  Brain Dev       Date:  2015-12-22       Impact factor: 1.961

3.  Mild phenotype in Pelizaeus-Merzbacher disease caused by a PLP1-specific mutation.

Authors:  Hitoshi Osaka; Shiro Koizume; Haruhiko Aoyama; Hiroko Iwamoto; Seiji Kimura; Jun-Ichi Nagai; Kenji Kurosawa; Sumimasa Yamashita
Journal:  Brain Dev       Date:  2009-12-21       Impact factor: 1.961

4.  Mild Pelizaeus-Merzbacher disease caused by a point mutation affecting correct splicing of PLP1 mRNA.

Authors:  C A Hübner; A Senning; U Orth; K Zerres; H Urbach; A Gal; S Rudnik-Schöneborn
Journal:  Neuroscience       Date:  2005       Impact factor: 3.590

5.  Steroid-responsive neurologic relapses in a child with a proteolipid protein-1 mutation.

Authors:  M P Gorman; M R Golomb; L E Walsh; G M Hobson; J Y Garbern; R P Kinkel; B T Darras; D K Urion; Y Z Eksioglu
Journal:  Neurology       Date:  2007-04-17       Impact factor: 9.910

6.  Identification and functional study of novel PLP1 mutations in Chinese patients with Pelizaeus-Merzbacher disease.

Authors:  Han Xie; Hongchun Feng; Jinhua Ji; Ye Wu; Liping Kou; Dongxiao Li; Haoran Ji; Xiru Wu; Zhengping Niu; Jingmin Wang; Yuwu Jiang
Journal:  Brain Dev       Date:  2014-12-06       Impact factor: 1.961

7.  Novel hypomyelinating leukoencephalopathy affecting early myelinating structures: clinical course in two brothers.

Authors:  Davide Tonduti; Anna Pichiecchio; Nicole I Wolf; Giada Ariaudo; Marjo S van der Knaap; Stefano Bastianello; Umberto Balottin; Simona Orcesi
Journal:  Neuropediatrics       Date:  2013-01-24       Impact factor: 1.947

8.  Neuroradiologic correlates of clinical disability and progression in the X-linked leukodystrophy Pelizaeus-Merzbacher disease.

Authors:  Jeremy J Laukka; Jeffrey A Stanley; James Y Garbern; Angela Trepanier; Grace Hobson; Tori Lafleur; Alexander Gow; John Kamholz
Journal:  J Neurol Sci       Date:  2013-08-30       Impact factor: 3.181

9.  Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Authors:  Sue Richards; Nazneen Aziz; Sherri Bale; David Bick; Soma Das; Julie Gastier-Foster; Wayne W Grody; Madhuri Hegde; Elaine Lyon; Elaine Spector; Karl Voelkerding; Heidi L Rehm
Journal:  Genet Med       Date:  2015-03-05       Impact factor: 8.822

10.  Altered PLP1 splicing causes hypomyelination of early myelinating structures.

Authors:  Sietske H Kevelam; Jennifer R Taube; Rosalina M L van Spaendonk; Enrico Bertini; Karen Sperle; Mark Tarnopolsky; Davide Tonduti; Enza Maria Valente; Lorena Travaglini; Erik A Sistermans; Geneviève Bernard; Coriene E Catsman-Berrevoets; Clara D M van Karnebeek; John R Østergaard; Richard L Friederich; Mahmoud Fawzi Elsaid; Jolanda H Schieving; Maja Tarailo-Graovac; Simona Orcesi; Marjan E Steenweg; Carola G M van Berkel; Quinten Waisfisz; Truus E M Abbink; Marjo S van der Knaap; Grace M Hobson; Nicole I Wolf
Journal:  Ann Clin Transl Neurol       Date:  2015-05-01       Impact factor: 4.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.